VXUS240920C62000
- 1.00
- +0.35+53.85%
Vanguard Total International Stock ETF Newsroom
Novartis Lower as BofA Downgrades on Risks to Valuation
Novartis Licenses Gene Therapy Component From Voyager
VXUS ETF Falls Wednesday
Novartis Expands U.S. Radiopharma Production Amid Rising Competition
Siemens Healthineers Seeks €200M Novartis Deal to Boost Cancer Imaging Business: FT
Earnings Summary: Novartis Beats Q2 Earnings Estimates; Raises 2024 Profit Forecast on Demand for New Drugs
Novartis Beats Top-line and Bottom-line Estimates; Raises FY24 Core Operating Income Outlook
Italy Probes European Pharma Giants Novartis, Roche Over Eye Drug Competition Allegations
Novartis, Roche Facing Italy Antitrust Probe Over Lucentis Biosimilar
Travere Gains on Novartis Data for Filspari Rival, Calliditas Buyout
Morgan Stanley Says Global Risk Assets Have 'Good Set-up' in H2 With Cooling Inflation
Kanzhun's Strong Quarter Overshadowed By Broad Sell-Off In Chinese Stocks: Details
HSBC Recommends Where to Invest Globally With Stocks Set to Rise Under Two Scenarios
Bitcoin Stock Canaan Up After Q1 Print, What's Going On?
Radiopharma Stocks Higher as Sector Welcomes the Latest M&A Deal
Novartis Beats Top-line and Bottom-line Estimates; Raises FY24 Outlook
FDA Requires Labeling Changes to CAR-T Cell Therapies to Reflect Cancer Risk
TG Therapeutics Wins VA Contract for Briumvi
CVS Favors Humira Copycats Hurting AbbVie's Market Share: Evercore
Looking At Novartis's Recent Unusual Options Activity